Essential hypertension is associated with changes in central catecholaminergic pathways which might also be reflected in the pituitary response to stress stimuli. The aim of this study was to determine whether the response of pituitary hormones, cortisol, plasma renin activity, aldosterone and catecholamines to insulininduced hypoglycaemia is changed in hypertension. We studied 22 young lean male patients with newly diagnosed untreated essential hypertension and 19 healthy normotensive, age-and body mass index (BMI)-matched controls. All subjects underwent an insulin tolerance test (0.1 IU insulin/kg body weight intravenously) with blood sampling before and 15, 30, 45, 60 and 90 min after insulin administration. Increased baseline levels of norepinephrine (Po0.05), increased response of norepinephrine (Po0.001) and decreased response of growth hormone (Po0.001), prolactin (Po0.001), adrenocorticotropic hormone (Po0.05) and cortisol (Po0.001) were found in hypertensive patients when compared to normotensive controls. Increased norepinephrine levels and a decreased pituitary response to metabolic stress stimuli may represent another manifestation of chronically increased sympathetic tone in early hypertension.
Introduction
Hypertension is a risk factor for cardiovascular morbidity and mortality. Already a modest elevation of blood pressure (BP) in grade 1 hypertension and high normal BP, prehypertension (previously borderline hypertension), is associated with multiple rheologic, haemodynamic, endocrine and metabolic changes. 1, 2 Increased sensitivity to stress stimuli is presumed to play an important role in the ethiopathogenesis of essential hypertension. [3] [4] [5] Adaptation to stress situations is mediated predominantly by the sympathoadrenal system and the hypothalamicpituitary-adrenocortical axis. 6, 7 Increased peripheral sympathetic activity is suggested to play a key role especially in the early phases of hypertension in young subjects. 3, 8 Furthermore, as reviewed by DeQuattro and Feng, 9 several research groups found increased norepinephrine levels in cerebrospinal fluid and increased norepinephrine turnover in hypothalamic centres of hypertensive (HT) subjects. Central catecholaminergic pathways transmit neural stimuli to neuroendocrine hypothalamic centres that regulate endocrine activity of pituitary cells. 10, 11 Somatotropic, lactotropic and adrenocorticotropic axes are activated differently by various stress stimuli. 12, 13 Therefore, we hypothesize hypertension to be associated with changes in central catecholaminergic pathways, and that these changes are reflected by changes in the pituitary response to stress stimuli.
Amerena and Julius 3 observed increased neuroendocrine response during exercise in young HT patients. However, the stress stimulus used (exercise) is dependent upon efficiency of the cardiovascular system; it is possible that increased neuroendocrine responses are due to a decreased level of cardiovascular fitness in HT patients. For that reason, we chose to utilize a metabolic stimulus which acts via a hypothalamic pathway (insulininduced hypoglycaemia) to determine whether responses of growth hormone, prolactin, adrenocorticotropic hormone (ACTH) and cortisol (as a measure of pituitary-adrenocortical function), plasma renin activity (PRA) and aldosterone (as a measure of mineralocorticoid function) and catecholamines (epinephrine and norepinephrine) are altered in young non-obese males with newly diagnosed untreated hypertension.
Subjects and methods
We studied 22 young non-obese male patients with essential hypertension (HT) recruited from the registry of the Department of Cardiology, Out-patient Clinic Karlova Ves, Bratislava, Slovakia. The diagnosis of HT was confirmed by 24-h BP measurement. Secondary HT was excluded by clinical examination, routine blood and urine analysis, and hormonal measurements before the study and only individuals with confirmed diagnosis of essential HT were enrolled. The patients had not been previously treated with antihypertensive drugs. Blood pressure was measured again in our laboratory on two separate occasions in duplicate seated measurements after 30 min stabilization period. None of the patients or controls had a history of diabetes or impaired glucose tolerance (as shown before the study by standard oral glucose tolerance testing). 15 Clinical characteristics of the groups are shown in Table 1 . Except HT, all patients and controls were in very good physical and mental health condition, taking no medication, nonsmokers. The study was approved by the Ethics Committee of the Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia. After explanation of the procedure, written informed consent was obtained from all participants.
Methods
The subjects were asked to refrain from the use of tobacco, alcohol, caffeine, any medication and heavy physical activity for 12 h before the study. The investigations started at 0800 after a 12-h overnight fast. An indwelling catheter was inserted into a cubital vein and the subjects were asked to rest in a comfortable armchair. After a 30 min rest, BP was measured using Dinamap Vital Signs Monitor (model 845 XT; Critikon Inc., Tampa, FL, USA) and baseline blood samples were taken. An intravenous bolus of insulin (0.1 IU/kg, Actrapid HM, Novo Nordisk, Denmark) was injected afterwards. Blood samples were taken 15, 30, 45, 60 and 90 min after insulin administration into polyethylene tubes containing ethylenediaminetetraacetic acid (EDTA) or heparin as anticoagulants, and immediately placed on ice. After centrifugation at 41C, plasma aliquots were stored frozen at À201C until assayed. Plasma glucose concentrations were measured using an automatic biochemical analyser by the glucose oxidase method (Hitachi 911, Japan). Plasma renin activity, aldosterone, ACTH and cortisol concentrations were determined by radioimmunoassay (RIA); growth hormone and prolactin levels were measured by immunoradiometric assay (IRMA); all using commercial kits (Immunotech, Marseille, France). Epinephrine and norepinephrine were measured with a radioenzymatic assay according to Peuler and Johnson. 16 Statistical evaluation was completed using the Sigma Stat 2.0 program (Jandel Scientific, San Rafael, CA, USA) and SPSS 11.5 program (SPSS Inc., Chicago, IL, USA). Comparison of single variables was performed using the Mann-Whitney 
Results
The plasma levels of norepinephrine at baseline were significantly higher in HT subjects than in NT controls (Table 1) . Baseline heart rate (HR) and BP were also significantly higher in HT than in NT subjects (Table 1 ). Plasma levels of aldosterone, ACTH, cortisol, prolactin, growth hormone, epinephrine and PRA at baseline did not differ between the groups (Table 1) . As shown in Figure 1 , insulin administration resulted in a significant decrease in plasma glucose concentrations in both groups (effect of time Po0.001, F ¼ 151.674) with similar nadir reached 30 min after insulin bolus (NT: 2.070.1 mmol/l vs HT: 2.070.1 mmol/l; NS); however, earlier recovery from hypoglycaemia was noted in HT subjects in 60 and 90 min only (effect of diagnosis Po0.05, F ¼ 5.506). The interactive differences were over the limit of statistical significance (effect of diagnosis Â time P ¼ 0.061, F ¼ 2.147).
An increase in HR (Figure 1 ) was observed in both groups during hypoglycaemia (effect of time Po0.001, F ¼ 5.086). Hypertensive patients had a higher HR during insulin-induced hypoglycaemia (effect of diagnosis Po0.01, F ¼ 9.16).
Systolic and diastolic BP increased during hypoglycaemia (Figure 1 ) (effect of time Po0.05, F ¼ 2.5). The systolic and diastolic BP were higher in HT subjects than in NT subjects during the entire investigation (effect of diagnosis Po0.001, F ¼ 25.6), with interactive differences in systolic BP (effect of diagnosis Â time P ¼ 0.04, F ¼ 2.402).
Hypoglycaemia resulted in an increase in epinephrine in HT and in NT subjects (effect of time Figure 1 Changes in plasma glucose, epinephrine and norepinephrine levels, as well as systolic and diastolic blood pressure and heart rate during insulin tolerance test in hypertensive patients (black circle) and normotensive controls (white circles). Statistical significance as revealed by two-way analysis of variance ANOVA for factors time, diagnosis (dg) and their interactions (time Â dg). Post hoc tests for significant differences in time vs diagnosis interactions: *Po0.05 for particular time intervals.
Endocrine response in hypertension Z Radikova et al Po0.001, F ¼ 32.8). The response of epinephrine to hypoglycaemia in HT was the same as in NT (Figure 1 ). Increased norepinephrine levels were observed in both groups during hypoglycaemia (effect of time Po0.01, F ¼ 3.873). The response of norepinephrine during insulin-induced hypoglycaemia was higher in HT subjects compared to NT controls (effect of diagnosis Po0.001, F ¼ 13.6); however, the increments from baseline to maximal response being comparable in both groups (P ¼ 0.45) (Figure 1 ).
Hypoglycaemia caused a significant increase in plasma growth hormone (GH) levels ( Figure 2 ) in both groups (effect of time Po0.001, F ¼ 39.797). The GH response was significantly lower in HT than in NT subject (effect of diagnosis Po0.001, F ¼ 16.639; effect of diagnosis Â time Po0.001, F ¼ 4.058).
A significant increase in prolactin (PRL) levels was observed in both groups during hypoglycaemia (effect of time Po0.001, F ¼ 15.746). The response of PRL during insulin-induced hypoglycaemia was significantly lower in HT subjects when compared to NT controls (effect of diagnosis Po0.001, F ¼ 14.246) (Figure 2) .
Adrenocorticotropic hormone levels significantly increased during hypoglycaemia (Figure 2 ; effect of time Po0.001, F ¼ 14.169). The ACTH response was lower in HT subjects than in NT subjects (effect of diagnosis Po0.05, F ¼ 4.655).
Hypoglycaemia caused a significant increase in plasma cortisol levels in both groups (effect of time Po0.001, F ¼ 36.8). The cortisol response was lower in HT subjects than in NT subject (effect of diagnose Po0.001, F ¼ 14.541; effect of diagnose Â time Po0.01, F ¼ 3.104).
Hypoglycaemia resulted in an increase in PRA in HT and in NT subjects (effect of time Po0.05, F ¼ 2.738). The response of PRA to hypoglycaemia in HT was not different from that found in NT.
No significant changes in plasma aldosterone concentrations were observed in the two groups during hypoglycaemia. Figure 2 Changes in plasma renin activity (PRA), plasma aldosterone, growth hormone (GH), prolactin, adrenocorticotropic hormone (ACTH) and cortisol levels during insulin tolerance test in hypertensive patients (black circle) and normotensive controls (white circles). Statistical significance as revealed by two-way analysis of variance ANOVA for factors time, diagnosis (dg) and their interactions (time Â dg). Post hoc tests for significant differences in time vs diagnosis interactions: *Po0.05 for particular time intervals.
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Discussion
In the present study we found decreased responses of growth hormone, ACTH, cortisol and PRL in young, lean, untreated male patients with hypertension during insulin-induced hypoglycaemia when compared to those in age-and BMI-matched NT controls.
In a traditional view, a reduction of stress response has been thought to be favourable. 17, 18 However, our results and previously found lower concentrations of ACTH, cortisol, prolactin and catecholamines in anxious subjects during psychosocial stress 19 do not support this suggestion. Altered neuroendocrine responsiveness of HT subjects to stress stimuli might also therefore be related to the state of the mood; however, our subjects did not suffer from any mood disorder.
Insulin-induced hypoglycaemia activates the neuroendocrine system by stimulation of central regulatory mechanisms. Glucopenia registered by glucosensitive neurons in the hypothalamus through monoamine transmission activates postsynaptic alpha-adrenergic receptors on peptidergic hypophyseotropic neurons 20 and initiates the secretion of growth hormone, PRL and ACTH (leading to cortisol response) 10, 21, 22 and neural stimulation of the adrenal medulla and of adrenergic nerve endings. 23 Glycemic thresholds for hormone release are 3.770.1 mmol/l for growth hormone, 24, 25 3.270.2 mmol/l for cortisol 24 and 2.470.1 mmol/l for PRL (means7s.d. all). 26 Following the pharmacological dose of insulin, the glucose concentration in our subjects decreased to an average of 2.2 mmol/l in the minute 30 of the insulin tolerance test, showing that HT as well as NT subjects had a sufficient decrease in plasma glucose levels to activate the hypothalamic-pituitary axis. [24] [25] [26] The stimulus for endocrine activation is the decrease of glycemia below glycemic thresholds, which was the same in HT patients and NT controls. A comparable degree of hypoglycaemia was observed in both groups also at 45 min, when the majority of hormonal responses had already reached the peak of their concentrations. Therefore, the observed trend to a faster recovery of plasma glucose to normal values in the 60-90 min after insulin administration in HT subjects did not influence the peak of hormonal responses. Decreased pituitary response to hypoglycaemia, as a result of an alteration in the sensitivity of hypothalamic glucoreceptors for neuroglucopenia, is also unlikely because of the comparable nadirs of hypoglycaemia, and the similar and adequate increase of epinephrine and angiotensin I during hypoglycaemia.
In general, functional secretory capacity of the pituitary gland is large in humans; the finding of a normal growth hormone response to the administration of growth hormone-releasing hormone in HT patients 27 also does not support the possibility that secretory defect underlies different hormonal responses in HT and NT subjects. Several investigators 9, [28] [29] [30] proposed an important role of the nervous system in the aetiology and pathogenesis of essential hypertension, particularly of the abnormalities of the sympathetic nervous system in the early phases of hypertension. Sustained increase in sympathetic activity was associated with decreased receptor density or decreased response to adrenergic agonists in several studies. [31] [32] [33] Circulating norepinephrine under euglycaemia is derived mostly from adrenergic sympathetic postganglionic neurons. However, under hypoglycaemia, plasma norepinephrine is derived largely from adrenal medulla together with main adrenal catecholamine-epinephrine. 34 Therefore, we found a discrepancy in epinephrine and norepinephrine response to hypoglycaemia in both HT and NT subjects. Increased baseline norepinephrine concentrations observed in HT subjects could reflect the increased norepinephrine levels in cerebrospinal fluid. [35] [36] [37] The elevated norepinephrine levels in cerebrospinal fluid and in the internal jugular venous overflow from subcortical brain regions 38, 39 may cause an alteration in noradrenergic receptors in several brain structures, including those responsible for release of pituitary hormones. It has been proposed that HT patients may have altered sensitivity of central alpha-adrenergic receptors on associated hypothalamic neurons. 40, 41 This hypothesis is supported by the data showing decreased response of growth hormone to a central pre-synaptic alpha-2 adrenergic agonist clonidine in HT patients. 27, 42 Clonidine stimulates growth hormone secretion from the pituitary gland through the endogenous release of growth hormone-releasing hormone by the hypothalamus. 43, 44 Therefore, the decreased growth hormone response to hypoglycaemia seen in our study may be explained by the desensitization of alpha-2 adrenergic receptors on growth hormone-releasing hormone neurons in the hypothalamus.
Intravenous infusion of alpha-adrenergic blockers causes a suppressed plasma cortisol response to insulin-induced hypoglycaemia in healthy males. 45 However, the role of alpha-adrenergic receptors in ACTH and PRL secretion has been investigated with several discrepant outcomes. Karhuvaara et al. 46 and Al-Damluji 21 found that alpha-2 adrenergic receptors are not involved in the secretion of PRL in humans. However, several animal studies showed equivocal effects of alpha-2 agonists and alpha-2 antagonists on PRL 11, [47] [48] [49] [50] and ACTH secretion.
11,51
On the other hand, intravenous infusion of alpha-1 adrenergic agonist stimulated PRL and ACTH secretion in healthy male volunteers, suggesting that the stimulated alpha-1 receptors are located centrally and not on the pituitary gland or in the periphery. 19, 21 On the basis of present knowledge, the clinical significance of attenuated responses of growth hormone, ACTH and PRL to stress stimuli in hypertension is not known. Some influence on the The results of our study showed an increased concentration of norepinephrine and decreased response of growth hormone, prolactin, ACTH (and cortisol) during hypoglycaemia in HT subjects. This abnormality could be another manifestation of chronically increased sympathetic tone in early hypertension, which may lead to a desensitization of central alpha-adrenergic receptors.
